Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Malaria Parasite Clearance: What Are We Really Measuring?
David S. Khoury, Sophie Zaloumis, Matthew J. Grigg, et al.
Trends in Parasitology (2020) Vol. 36, Iss. 5, pp. 413-426
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Antimalarial Drug Resistance and Implications for the WHO Global Technical Strategy
Matthew M. Ippolito, Kara A. Moser, Jean-Bertin Bukasa Kabuya, et al.
Current Epidemiology Reports (2021) Vol. 8, Iss. 2, pp. 46-62
Open Access | Times Cited: 96
The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro
Annabelle Walz, Maëlle Duffey, Ghaith Aljayyoussi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 163-163
Open Access | Times Cited: 16
‘Artemisinin Resistance’: Something New or Old? Something of a Misnomer?
Thomas E. Wellems, Juliana M. Sá, Xin‐zhuan Su, et al.
Trends in Parasitology (2020) Vol. 36, Iss. 9, pp. 735-744
Closed Access | Times Cited: 35
New insights into the spread of resistance to artemisinin and its analogues
Noreen Noreen, Asad Ullah, Syed Muhammad Salman, et al.
Journal of Global Antimicrobial Resistance (2021) Vol. 27, pp. 142-149
Open Access | Times Cited: 25
Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and Malaria
Sijongesonke Peter, Siphesihle Jama, Sibusiso Alven, et al.
Molecules (2021) Vol. 26, Iss. 24, pp. 7521-7521
Open Access | Times Cited: 25
Inaccurate communication in health sciences: the case of ‘partial artemisinin resistance’ for the treatment of malaria
Thomas Hänscheid, Sara M Mahomed, Maria Rebelo, et al.
New Microbes and New Infections (2024) Vol. 62, pp. 101544-101544
Open Access | Times Cited: 3
New In Vitro Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial Combinations
Sebastian G. Wicha, Annabelle Walz, Mohammed H. Cherkaoui‐Rbati, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 11
Open Access | Times Cited: 12
Variability in white blood cell count during uncomplicated malaria and implications for parasite density estimation: a WorldWide Antimalarial Resistance Network individual patient data meta-analysis
Elke Wynberg, Robert J. Commons, Georgina Humphreys, et al.
Malaria Journal (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Quantification of Plasmodium falciparum HRP-2 as an alternative method to [3H]hypoxanthine incorporation to measure the parasite reduction ratio in vitro
Laís Pessanha de Carvalho, Elena Niepoth, Arbreshe Mavraj-Husejni, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 3, pp. 106894-106894
Closed Access | Times Cited: 6
Therapeutic Efficacy of Artemether–Lumefantrine for Uncomplicated Falciparum Malaria in Northern Zambia
Matthew M. Ippolito, Julia C. Pringle, Mwiche Siame, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 103, Iss. 6, pp. 2224-2232
Open Access | Times Cited: 15
Parasite Viability as a Superior Measure of Antimalarial Drug Activity in Humans
Maria Rebelo, Rebecca Pawliw, Jeremy Gower, et al.
The Journal of Infectious Diseases (2020) Vol. 223, Iss. 12, pp. 2154-2163
Closed Access | Times Cited: 12
Hospitalization status and gender recognition over the arboviral medical records using shallow and RNN-based deep models
Kutlucan Görür, Onursal Çetin, Zeynep Ozer, et al.
Results in Engineering (2023) Vol. 18, pp. 101109-101109
Open Access | Times Cited: 4
An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria
Sompob Saralamba, J. A. Simpson, Noppon Choosri, et al.
Journal of Antimicrobial Chemotherapy (2023) Vol. 78, Iss. 9, pp. 2192-2202
Open Access | Times Cited: 4
Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment
Georges F. R. Radohery, Annabelle Walz, Christin Gumpp, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 7
Open Access | Times Cited: 7
Quantification of parasite clearance in Plasmodium knowlesi infections
Jeyamalar T Thurai Rathnam, Matthew J. Grigg, S Dini, et al.
Malaria Journal (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice
Arya SheelaNair, Aleksandra S. Romanczuk, Rosemary A. Aogo, et al.
Malaria Journal (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Effect of novel antimalarial ZY-19489 on Plasmodium falciparum viability in a volunteer infection study
Georges F. R. Radohery, Jeremy Gower, Bridget E. Barber, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 6, pp. 760-761
Open Access | Times Cited: 3
Plasmodium knowlesi (Pk) Malaria: A Review & Proposal of Therapeutically Rational Exchange (T-REX) of Pk-Resistant Red Blood Cells
Ryan Philip Jajosky, Shang‐Chuen Wu, Philip G. Jajosky, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 10, pp. 478-478
Open Access | Times Cited: 1
Promising role of phenolic acids as antimalarial and antiviral drugs
Fabricio E. Freije García, Sofía C. Bravo, Guadalupe García Liñares
Elsevier eBooks (2024), pp. 211-254
Closed Access
Current Status on 1,4-Dihydropyridine Derivatives against Human Pathogenic Parasites
Orlando G. Elso, Guadalupe García Liñares, Valeria P. Sülsen
Current Medicinal Chemistry (2022) Vol. 30, Iss. 15, pp. 1689-1711
Closed Access | Times Cited: 2
A literature study of anemia among malaria cases reported in Indonesia, from west to east: a parasito-epidemiology perspective
Forman Erwin Siagian
International Journal of Community Medicine and Public Health (2020) Vol. 7, Iss. 10, pp. 4135-4135
Open Access | Times Cited: 1
A new in vitro checkerboard-parasite reduction ratio interaction assay for early de-risk of clinical development of antimalarial combinations
Sebastian G. Wicha, Annabelle Walz, Mohammed H. Cherkaoui‐Rbati, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
A Novel Strategy for P. falciparum Malaria based on Syk Kinase Inhibitors to Design Triple Artemisininbased Combination Therapies (TACTs) to Counteract Delayed Parasite Clearance (Drug Resistance) Following Standard ACT Treatment
Francesco Turrini, Philip S. Low, Huynh Dinh Chien
(2021) Vol. 4, Iss. 1
Open Access | Times Cited: 1
An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria
Sompob Saralamba, J. A. Simpson, Noppon Choosri, et al.
Research Square (Research Square) (2023)
Open Access
An improved pharmacometric model for artesunate treatment of falciparum malaria
Sompob Saralamba, J. A. Simpson, Noppon Choosri, et al.
Research Square (Research Square) (2022)
Open Access
Page 1 - Next Page

Scroll to top